If new information becomes available that may affect a subject's willingness to continue participation, who should be informed?

Prepare for the ICH Good Clinical Practice (GCP) Exam for Certified Clinical Research Coordinator with engaging multiple-choice questions and detailed explanations. Elevate your understanding and expertise to excel in your certification exam!

Multiple Choice

If new information becomes available that may affect a subject's willingness to continue participation, who should be informed?

Explanation:
When new information arises that could influence a participant’s decision to continue, you must inform the person who is participating in the study. The subject or, if they cannot consent themselves, the subject’s legally acceptable representative, is the one who should be informed so they can decide whether to stay in the trial. The investigator is responsible for communicating that information clearly and, if needed, obtaining updated consent. Informing the sponsor alone or not informing anyone would not uphold the participant’s right to make an informed decision about continued participation.

When new information arises that could influence a participant’s decision to continue, you must inform the person who is participating in the study. The subject or, if they cannot consent themselves, the subject’s legally acceptable representative, is the one who should be informed so they can decide whether to stay in the trial. The investigator is responsible for communicating that information clearly and, if needed, obtaining updated consent. Informing the sponsor alone or not informing anyone would not uphold the participant’s right to make an informed decision about continued participation.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy